Strong Revenue Growth
Revenue for Q3 2024 increased by 12% compared to the previous year, driven by unit sales growth of 6% in the U.S. and 9% in Europe.
Positive EBITDA
The EBITDA for Q3 was NOK 5 million, marking the sixth consecutive quarter of positive EBITDA.
Successful Rollout of ForTec Mobile Strategy
The ForTec mobile strategy contributed to 3% of total U.S. sales, with 36 accounts using the service by the end of October.
European Market Expansion
Priority growth markets such as the U.K., Italy, and France grew by 12%, with significant momentum in Germany at 11% growth.
Early Approval of Hexvix in China
Hexvix was approved six months ahead of schedule in China, with high-quality Phase III data recognized by the Chinese NMPA.
Cash Flow and Balance Sheet
Photocure ended Q3 with a cash balance of NOK 291 million, up NOK 24.1 million from the previous year.